Embed Size (px)
Citation preview
Clinical Protocol CA209067BMS-936558 Nivolumab
APPENDIX 4 RECOMMENDED MANAGEMENT ALGORITHMS FOR SUSPECTED PULMONARY TOXICITY, DIARRHEA/COLITIS, SUSPECTED HEPATOTOXICITY, SUSPECTED ENDOCRINOPATHY, NEPHROTOXICITY, SKIN TOXICITY, AND NEUROLOGIC TOXICITY
Date: 19-Mar-2013 114930067689 1.01.0Approved v
Clinical Protocol CA209067BMS-936558 Nivolumab
Date: 19-Mar-2013 115930067689 1.01.0Approved v
Clinical Protocol CA209067BMS-936558 Nivolumab
Date: 19-Mar-2013 116930067689 1.01.0Approved v
Clinical Protocol CA209067BMS-936558 Nivolumab
Date: 19-Mar-2013 117930067689 1.01.0Approved v
Clinical Protocol CA209067BMS-936558 Nivolumab
Date: 19-Mar-2013 118930067689 1.01.0Approved v
Clinical Protocol CA209067BMS-936558 Nivolumab
Date: 19-Mar-2013 119930067689 1.01.0Approved v
Clinical Protocol CA209067BMS-936558 Nivolumab
Date: 19-Mar-2013 120930067689 1.01.0Approved v
